TARRYTOWN, N.Y. (AP) _ Regeneron Pharmaceuticals Inc. (REGN) on Wednesday reported first-quarter net income of $973.5 million.The Tarrytown, New York-based company said it had profit of $8.61 per share. Earnings, adjusted for non-recurring costs, were $11.49 per share.The results exceeded Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was for earnings of $9.37 per share.The biopharmaceutical company posted revenue of $2.97 billion in the period, also topping Street forecasts. Five analysts surveyed by Zacks expected $2.71 billion._____This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on REGN at https://www.zacks.com/ap/REGN